KineMed Inc.

https://www.kinemed.com

KineMed is a commercial-stage company focused on applying its proprietary biomarker platform technology to drug development, prescription and non-prescription medical diagnostics and the pairing of drugs with diagnostic biomarker tests. KineMed's diagnostic biomarker tests directly measure the biological processes that cause disease by revealing the flux, or rate of production and destruction, over a period of time, of the key molecules involved in these biological processes. KineMed believes that measuring molecular fluxes can provide interpretable information that may be predictive for clinically meaningful endpoints for a particular patient and are designed to reveal personalized information for a patient that can guide healthcare decisions. As a result, KineMed believes KineMed's biomarkers have the potential to have a transformative effect on healthcare by providing information that can be used to make drug development more efficient, and guide healthcare decisions by physicians and wellness decisions by consumers. Building on a legacy of collaborative relationships and experience performing biomarker tests in human disease research and drug development settings, KineMed is currently focused on commercializing biomarker tests in six areas: muscle biology, fibrotic diseases, neurodegenerative diseases, cardiometabolic diseases, skincare and cancer. KineMed's muscle biology program represents its most advanced initiative that focuses its proprietary technology on a long-standing need in medicine and wellness management. *

	Start	2005-03-01 existent
	Industry	drug development services
	Industry 2	mass spectrometry services (MS services)
	Person	Kiron, Ravi (KineMed 201401 CBO)

	Region	Emeryville, CA
	Country	United States (USA)
	Street	5980 Horton Street Suite 470
	City	94608 Emeryville, CA
	Tel	+1-510-655-6525
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Kenes Exhibitions Biomed Israel 2024 Tel Aviv 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)